Literature DB >> 23517503

Viruses and type 1 diabetes: a new look at an old story.

Maria E Craig1, Sandhya Nair, Hayley Stein, William D Rawlinson.   

Abstract

Epidemiological data suggesting an infectious origin of diabetes pre-date the discovery of insulin; indeed it was the variation in mortality rates from diabetes that led Gunderson to hypothesise that a virus with 'selective affinity for the pancreas' may cause 'acute diabetes' in youth (1). He noted an increase in deaths from diabetes in young people aged 10-20 yr in Norway from 1900 to 1921 following epidemics of parotitis, with a lag time of 3-4 yr between infection and death. In Norway, Denmark,France, and America, the increase in deaths from diabetes exceeded the expected number based on population growth; lending further weight to the proposal that diabetes was caused by infection. Since that time,a large body of epidemiological, clinical and experimental research, in humans, cellular and animal models, has provided further insights into the contribution of infections in the development of type 1 diabetes.Epidemiological evidence for a viral aetiology of diabetes A substantial body of epidemiological data point to a significant contribution of the environment in the development of type 1 diabetes,although much of the evidence is not specific to viruses per se. These data include rising rates of type 1 diabetes in both developed and developing countries in recent decades (2, 3) and a reduced contribution of high risk human leucocyte antigen (HLA) genotypes (4, 5), indicating that non-genetic factors are important. Similarly, the pairwise concordance between monozygotic twins for type 1 diabetes of less than 40%, and the observation that the incidence of diabetes in migrant children reflects that of their adopted country (6, 7), provide circumstantial evidence that environmental agents contribute to the disease. Space-time clustering in the presentation of type 1 diabetes (8-10) and clustering of births in children who subsequently develop diabetes (11) support a direct role for infections in the initiation and acceleration of the disease process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23517503     DOI: 10.1111/pedi.12033

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  30 in total

Review 1.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 2.  Enteroviral Infections as a Trigger for Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

3.  Antiviral antibody profiling by high-density protein arrays.

Authors:  Xiaofang Bian; Peter Wiktor; Peter Kahn; Al Brunner; Amritpal Khela; Kailash Karthikeyan; Kristi Barker; Xiaobo Yu; Mitch Magee; Clive H Wasserfall; David Gibson; Madeleine E Rooney; Ji Qiu; Joshua LaBaer
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

Review 4.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

Review 5.  MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections.

Authors:  Sonia R Isaacs; Jie Wang; Ki Wook Kim; Congcong Yin; Li Zhou; Qing Sheng Mi; Maria E Craig
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

Review 6.  Pancreatic pathology in type 1 diabetes mellitus.

Authors:  Sarah J Richardson; Noel G Morgan; Alan K Foulis
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

7.  Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study.

Authors:  Christopher C Patterson; Valma Harjutsalo; Joachim Rosenbauer; Andreas Neu; Ondrej Cinek; Torild Skrivarhaug; Birgit Rami-Merhar; Gyula Soltesz; Jannet Svensson; Roger C Parslow; Conxa Castell; Eugen J Schoenle; Polly J Bingley; Gisela Dahlquist; Przemysława K Jarosz-Chobot; Dalė Marčiulionytė; Edna F Roche; Ulrike Rothe; Natasa Bratina; Constantin Ionescu-Tirgoviste; Ilse Weets; Mirjana Kocova; Valentino Cherubini; Natasa Rojnic Putarek; Carine E deBeaufort; Mira Samardzic; Anders Green
Journal:  Diabetologia       Date:  2018-11-28       Impact factor: 10.122

8.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

Review 9.  Death waits for no man--does it wait for a virus? How enteroviruses induce and control cell death.

Authors:  Katharine G Harris; Carolyn B Coyne
Journal:  Cytokine Growth Factor Rev       Date:  2014-08-15       Impact factor: 7.638

10.  A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.

Authors:  Chester A Alper; Charles E Larsen; Michael R Trautwein; Dennis R Alford
Journal:  J Autoimmun       Date:  2018-10-08       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.